Safia Habib
- Molecular Biology
- Clinical Biochemistry top 1%
- Endocrinology, Diabetes and Metabolism top 5%
- Physiology
- Immunology
- Co-authors
- Asif AliMoinuddin MoinuddinKhursheed AlamAbdul Rouf MirSaheem AhmadUzma ShahabSidra IslamMudassir Alam
- Topics
- Advanced Glycation End Products research (20 papers)DNA and Nucleic Acid Chemistry (6 papers)Diabetes and associated disorders (6 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEInternational Journal of Biological Macromolecules
- Partner nations
- IndiaUnited StatesSaudi Arabia
In The Last Decade
Safia Habib
61 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Molecular Biology 353
- Clinical Biochemistry 296
- Endocrinology, Diabetes and Metabolism 210
- Physiology 165
- Immunology 133
Countries citing papers authored by Safia Habib
This map shows the geographic impact of Safia Habib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Safia Habib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Safia Habib more than expected).
Fields of papers citing papers by Safia Habib
This network shows the impact of papers produced by Safia Habib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Safia Habib. The network helps show where Safia Habib may publish in the future.
Co-authorship network of co-authors of Safia Habib
This figure shows the co-authorship network connecting the top 25 collaborators of Safia Habib. A scholar is included among the top collaborators of Safia Habib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Safia Habib. Safia Habib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 3 | |
| 8 | 5 | |
| 9 | 0 | |
| 10 | 5 | |
| 11 | 1 | |
| 12 | Role of Beta-Blockers as an Effective Cardio protective Agents, an insight in to Tackling with Cardiovascular Diseases (CVDs) and Hypertension | 1 |
| 13 | 2 | |
| 14 | 6 | |
| 15 | 33 | |
| 16 | 61 | |
| 17 | 20 | |
| 18 | 14 | |
| 19 | 24 | |
| 20 | 25 |
About Safia Habib
Safia Habib is a scholar working on Clinical Biochemistry, Cancer Research and Immunology, having authored 64 papers that have together received 1.1k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (20 papers), DNA and Nucleic Acid Chemistry (6 papers) and Diabetes and associated disorders (6 papers). The work is most often cited by research in Clinical Biochemistry (296 citations), Endocrinology, Diabetes and Metabolism (210 citations) and Biochemistry (46 citations). Safia Habib has collaborated with scholars based in India, United States and Saudi Arabia. Frequent co-authors include Asif Ali, Moinuddin Moinuddin, Khursheed Alam, Abdul Rouf Mir, Saheem Ahmad, Uzma Shahab, Sidra Islam, Mudassir Alam, Irfan Qadir Tantry and Kiran Dixit. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.